Evidence map›Paper›PMID 26675285›Full record

ArticleDementia and geriatric cognitive disorders extra

Epidemiology of Frontotemporal Lobar Degeneration in Northern Finland.

Laura Luukkainen, Risto Bloigu, Virpi Moilanen, Anne Marja Remes

Open access · goldAbstract read
In one paragraph

Article in Dementia and geriatric cognitive disorders extra. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. High Risk of Suicide in Behavioral Variant Frontotemporal Dementia.American journal of Alzheimer's disease and other dementias · 2019
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Laura LuukkainenDepartment of Neurology, Institute of Clinical Medicine, University of Oulu, Oulu, Finland ; Department of Neurology, Oulu University Hospital, Oulu, Finland.
Risto BloiguMedical Informatics Group, University of Oulu, Oulu, Finland.
Virpi MoilanenDepartment of Neurology, Oulu University Hospital, Oulu, Finland.
Anne Marja RemesDepartment of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland ; Department of Neurology, Kuopio University Hospital, Kuopio, Finland.
Oulu University Hospital · FIKuopio University Hospital · FIUniversity of Oulu · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFrontotemporal lobar degeneration (FTLD) is responsible for as many as every fifth case of early-onset dementia. Very few epidemiological studies of FTLD have been conducted; there are no published epidemiological data of FTLD from Finland or the other Nordic countries. The C9ORF72 expansion-associated FTLD is common in Finland; thus, the prevalence of FTLD is expected to be high in this population.

methodsWe retrospectively evaluated the incidence and prevalence of FTLD in university hospital settings in Northern Finland.

resultsThe mean 1-year incidence of FTLD was 5.54/100,000 (range 1.9-11.3/100,000) in the population aged 45-65 years. The prevalence of FTLD in the same age group was 20.5/100,000.

conclusionThe incidence and prevalence of FTLD in Finland seem to be the highest in Europe. However, studies from different countries may not be directly mutually comparable due to methodological issues.

Indexed as

Behavioral variantEpidemiologyFrontotemporal dementiaIncidencePrevalenceProgressive nonfluent aphasiaSemantic dementia

Identifiers

PMID26675285
PMCPMC4677706
OpenAlexW2252691563

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.